Inventor · disambiguated record
Karen L. Fearon
Also filed as: FEARON KAREN L
29 granted patents·6 pending applications·1,588 citations·filing 1989–2022
98Inventor score
Top patents by PatentIndex Score
35 records- 0197US8003115B2Chimeric immunomodulatory compounds and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Aug 23, 2011·41 cites·6 claims
- 0297US7255868B2Chimeric immunomodulatory compounds and methods of using the same—IDYNAVAX TECH CORP·Filed 2002·Granted Aug 14, 2007·83 cites·25 claims
- 0396US7250403B2Biodegradable immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Jul 31, 2007·71 cites·53 claims
- 0496US7183111B2Immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Feb 27, 2007·76 cites·41 claims
- 0595US8372413B2Immunomodulatory polynucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Feb 12, 2013·30 cites·22 claims
- 0695US8158768B2Immunostimulatory sequence oligonucleotides and methods of using the sameDINA DINO·Filed 2009·Granted Apr 17, 2012·38 cites·12 claims
- 0795US8124590B2Biodegradable immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2007·Granted Feb 28, 2012·33 cites·23 claims
- 0893US9422564B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2014·Granted Aug 23, 2016·15 cites·17 claims
- 0993US8871732B2Immunostimulatory sequence oligonucleotides and methods of using the sameDINA DINO·Filed 2012·Granted Oct 28, 2014·22 cites·13 claims
- 1093US8597665B2Chimeric immunomodulatory compounds and methods of using the same-IVFEARON KAREN L·Filed 2012·Granted Dec 3, 2013·16 cites·18 claims
- 1193US8222398B2Chimeric immunomodulatory compounds and methods of using the same-IIFEARON KAREN L·Filed 2008·Granted Jul 17, 2012·16 cites·34 claims
- 1293US5151510AMethod of synethesizing sulfurized oligonucleotide analogsAPPLIED BIOSYSTEMS·Filed 1990·Granted Sep 29, 1992·475 cites·17 claims
- 1393US5135717ATetrabenztriazaporphyrin reagents and kits containing the sameBRITISH TECH GROUP USA·Filed 1989·Granted Aug 4, 1992·129 cites·16 claims
- 1492US10196643B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2016·Granted Feb 5, 2019·8 cites·17 claims
- 1592US8114418B2Chimeric immunomodulatory compounds and methods of using the same—IVFEARON KAREN L·Filed 2002·Granted Feb 14, 2012·32 cites·15 claims
- 1691US9868955B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 16, 2018·11 cites·20 claims
- 1791US9028845B2Chimeric immunomodulatory compounds and methods of using the same-IVDYNAVAX TECH CORP·Filed 2013·Granted May 12, 2015·10 cites·9 claims
- 1891US8669237B2Biodegradable immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2012·Granted Mar 11, 2014·13 cites·22 claims
- 1990US7785610B2Chimeric immunomodulatory compounds and methods of using the same—IIIDYNAVAX TECH CORP·Filed 2002·Granted Aug 31, 2010·39 cites·7 claims
- 2090US7745606B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2003·Granted Jun 29, 2010·39 cites·10 claims
- 2189US8586555B2Immunomodulatory compositions, formulations, and methods for use thereofFEARON KAREN L·Filed 2009·Granted Nov 19, 2013·12 cites·37 claims
- 2289US5346670APhthalocyanine and tetrabenztriazaporphyrin reagentsBRITISH TECH GROUP USA·Filed 1992·Granted Sep 13, 1994·104 cites·25 claims
- 2387US9228184B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 5, 2016·10 cites·28 claims
- 2483US5494793AMonomeric phthalocyanine reagentsBRITISH TECH GROUP USA·Filed 1989·Granted Feb 27, 1996·129 cites·8 claims
- 2582US7625872B2Branched immunomodulatory compounds and methods of using the sameDYNAVAX TECH CORP·Filed 2003·Granted Dec 1, 2009·15 cites·2 claims
- 2680US2022267772A1Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2778US5824793ASolid phase synthesis of oligonucleotide N3'-P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Oct 20, 1998·48 cites·58 claims
- 2876US11312965B2Immunostimulatory sequence oligonucleotides and methods of using the sameTRISALUS LIFE SCIENCES INC·Filed 2018·Granted Apr 26, 2022·0 cites·13 claims
- 2974US5998604APolynucleotide purification methodPERKIN ELMER CORP·Filed 1997·Granted Dec 7, 1999·35 cites·20 claims
- 3074US5859233ASynthons for synthesis of oligonucleotide N3-P5 phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Jan 12, 1999·38 cites·8 claims
- 3158US2007258994A1Immunomodulatory formulations and methods for use thereofVAN NEST GARY·Filed 2007·Application pending·0 cites
- 3258US2015297737A1Chimeric immunomodulatory compounds and methods of using the same-ivDYNAVAX TECH CORP·Filed 2015·Application pending·0 cites
- 3349US2003133988A1Immunomodulatory compositions, formulations, and methods for use thereofFiled 2002·Application pending·0 cites
- 3448US2004132677A1Chimeric immunomodulatory compounds and methods of using the same-IVFiled 2003·Application pending·0 cites
- 3547US2003049266A1Immunomodulatory polynucleotides and methods of using the sameFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karen L. Fearon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →